Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Ole B. Suhr, Teresa Coelho et al.|New England Journal of Medicine|2018Cited by 2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D. Benson, Teresa Coelho, Márcia Waddington‐Cruz et al.|New England Journal of Medicine|2018Cited by 1.4k
Repurposing Diflunisal for Familial Amyloid PolyneuropathyJohn L. Berk, P. James B. Dyck, Ole B. Suhr et al.|JAMA|2013Cited by 701
Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profilesGeorgios Mangioris, Αναστασία Ζεκερίδου, Þorvarður R. Hálfdánarson et al.|European Journal of Neurology|2024Cited by 3